Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,911,467
-$531,349 QoQ
Shares Held
38,875
-0.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#585
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BRADLEY FOSTER & SARGENT INC/CT holds $254,262,538 across 12 Drug Manufacturers - General names. GILD ranks #7 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
333,906 | $84,802,106 | |
| 2 | ABBV |
AbbVie Inc.
|
219,509 | $55,237,244 | |
| 3 | LLY |
ELI LILLY & Co
|
35,186 | $42,203,147 | |
| 4 | MRK |
Merck & Co., Inc.
|
287,164 | $36,900,574 | |
| 5 | PFE |
Pfizer Inc
|
678,377 | $16,335,318 | |
| 6 | AMGN |
Amgen Inc
|
13,889 | $5,029,484 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
38,875 | $4,911,467 | |
| 8 | NVS |
Novartis AG
|
17,635 | $2,763,757 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,911,467 | 38,875 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,442,816 | 39,053 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,981,893 | 40,589 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,077,030 | 36,730 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,087,998 | 36,872 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,753,787 | 33,501 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,199,234 | 34,635 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $3,209,562 | 38,282 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,701,930 | 39,381 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,837,631 | 38,739 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,516,320 | 43,406 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,491,004 | 46,584 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,590,228 | 46,584 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $3,665,531 | 44,179 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $3,777,142 | 43,997 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,689,437 | 43,596 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,686,509 | 43,464 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,627,095 | 44,190 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,541,697 | 48,777 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $3,086,881 | 44,193 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,040,719 | 44,158 | Shares | Sole | 2021-08-19 | |
| 2021-03-31 | $2,776,117 | 42,954 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $2,496,033 | 42,843 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $3,463,570 | 54,812 | Shares | Sole | 2020-10-26 | |
| 2020-03-31 | $2,735,767 | 36,594 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||